BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31648806)

  • 21. Risk factors and outcomes of culture-proven acute Coccidioides spp. infection in San Diego, California, United States.
    Jenks JD; Reed SL; Hoenigl M
    Mycoses; 2020 Jun; 63(6):553-557. PubMed ID: 32176829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Rise of
    Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
    Front Immunol; 2019; 10():2188. PubMed ID: 31572393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful kidney transplantation after coccidioidal meningitis.
    Kokseng SL; Blair JE
    Transpl Infect Dis; 2011 Jun; 13(3):285-9. PubMed ID: 21040281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coccidioidal Hepatic Abscess in a Patient With Disseminated Coccidioidomycosis: A Case Report.
    Raza N; Nasrawi F; Heidari A; Kuran R; Amin N; Johnson R
    J Investig Med High Impact Case Rep; 2021; 9():23247096211033051. PubMed ID: 34311612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coccidioidomycosis: a review and update.
    DiCaudo DJ
    J Am Acad Dermatol; 2006 Dec; 55(6):929-42; quiz 943-5. PubMed ID: 17110216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coccidioidomycosis: Recent Updates.
    Twarog M; Thompson GR
    Semin Respir Crit Care Med; 2015 Oct; 36(5):746-55. PubMed ID: 26398540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural History of Disseminated Coccidioidomycosis: Examination of the Veterans Affairs-Armed Forces Database.
    Bays DJ; Thompson GR; Reef S; Snyder L; Freifeld AJ; Huppert M; Salkin D; Wilson MD; Galgiani JN
    Clin Infect Dis; 2021 Dec; 73(11):e3814-e3819. PubMed ID: 32778863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment considerations in pulmonary coccidioidomycosis.
    Hartmann CA; Aye WT; Blair JE
    Expert Rev Respir Med; 2016 Oct; 10(10):1079-91. PubMed ID: 27635942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Life Cycle Dominates the Volatilome Character of Dimorphic Fungus
    Higgins Keppler EA; Mead HL; Barker BM; Bean HD
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coccidioidomycosis of the genitourinary tract: a case report and discussion.
    Satyanarayan A; Klotz S; Han L; Sobonya R; Zangeneh TT
    Urology; 2014 Dec; 84(6):e30-1. PubMed ID: 25306476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early Events in Coccidioidomycosis.
    Donovan FM; Shubitz L; Powell D; Orbach M; Frelinger J; Galgiani JN
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31619396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs.
    O'Shaughnessy E; Yasinskaya Y; Dixon C; Higgins K; Moore J; Reynolds K; Ampel NM; Angulo D; Blair JE; Catanzaro A; Galgiani JN; Garvey E; Johnson R; Larwood DJ; Lewis G; Purdie R; Rex JH; Shubitz LF; Stevens DA; Page SJ; Shukla SJ; Farley JJ; Nambiar S
    Clin Infect Dis; 2022 Jun; 74(11):2061-2066. PubMed ID: 34651656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coccidioidomycosis.
    Galgiani JN
    West J Med; 1993 Aug; 159(2):153-71. PubMed ID: 8212681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal septic shock due to disseminated coccidioidomycosis: a case series and review of the literature.
    Wisniewski P; McCool I; Walsh JC; Ausman C; Edmondson J; Perry A; Ewers EC; Maves RC
    BMC Infect Dis; 2023 Jun; 23(1):430. PubMed ID: 37365503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coccidioidomycosis: efficacy of new agents and future prospects.
    Deresinski SC
    Curr Opin Infect Dis; 2001 Dec; 14(6):693-6. PubMed ID: 11964886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coccidioidomycosis: a reemerging infectious disease.
    Kirkland TN; Fierer J
    Emerg Infect Dis; 1996; 2(3):192-9. PubMed ID: 8903229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.
    Nguyen C; Barker BM; Hoover S; Nix DE; Ampel NM; Frelinger JA; Orbach MJ; Galgiani JN
    Clin Microbiol Rev; 2013 Jul; 26(3):505-25. PubMed ID: 23824371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Response to Coccidioidomycosis and the Development of a Vaccine.
    Castro-Lopez N; Hung CY
    Microorganisms; 2017 Mar; 5(1):. PubMed ID: 28300772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent pulmonary infection with an azole-resistant Coccidioides species.
    Kriesel JD; Sutton DA; Schulman S; Fothergill AW; Rinaldi MG
    Med Mycol; 2008 Sep; 46(6):607-10. PubMed ID: 18608910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coccidioides (spherulin) skin testing in patients with pulmonary coccidioidomycosis in an endemic region†.
    Mafi N; Murphy CB; Girardo ME; Blair JE
    Med Mycol; 2020 Jul; 58(5):626-631. PubMed ID: 31578560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.